♟️ Monday 28 July 2025 Mon, 28 July 2025

Comet Resources has sold a significant stake in International Graphite, using part of the proceeds to clear its debt, triggering a board resignation and signaling a shift in shareholder dynamics.

Peninsula Energy has completed a major reset of its uranium offtake contracts, terminating five of six agreements with a $6.6 million payout, while advancing commissioning of its Central Processing Plant toward first yellowcake production in Q3 2025.

Emyria has secured a landmark multi-year funding agreement with Medibank to reimburse PTSD patients under its Empax program, alongside opening a second clinic and reporting durable clinical improvements in treatment-resistant PTSD cases.

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.

Clarity Pharmaceuticals has completed a $203 million institutional placement at a premium, bolstering its cash reserves to nearly $288 million and positioning the company to advance pivotal clinical trials and commercial preparations for its cancer-fighting radiopharmaceuticals.

Adrad Holdings has appointed Paul Proctor as interim CEO following Kevin Boyle's resignation, while maintaining a steady earnings forecast for FY25.

Centaurus Metals reports strong value engineering results for its Jaguar Nickel Sulphide Project, confirming a 15-year mine life and first quartile costs, while advancing exploration at Boi Novo and Jambreiro iron ore projects.

Viking Mines reports significant gold discoveries at its Riverina East Project, including a new large gold anomaly and high-grade drill intercepts, alongside a promising underground mining study at First Hit.

ClearVue Technologies has appointed Douglas Hunt as its permanent Global CEO, unveiling a refreshed leadership team focused on scaling sales, manufacturing, and product innovation. The new executives have agreed to sub-market pay until the share price hits 35 cents, signaling strong alignment with shareholder interests.

Australian Strategic Materials has successfully raised A$13 million through an institutional placement, complementing an oversubscribed Share Purchase Plan to total nearly A$25 million. These funds will accelerate ASM’s metallisation expansion in the US and ramp up production at its Korean Metals Plant.

NeuroScientific Biopharmaceuticals has appointed Nathan Smith as CEO, leveraging his deep cell therapy expertise to accelerate clinical development and commercialisation of its StemSmart technology.

Pureprofile Limited reported record FY25 results, achieving 19% revenue growth and launching new AI-driven data solutions to fuel future expansion.

Norfolk Metals has successfully raised $3.5 million in an oversubscribed placement to fund its maiden drilling program at the Carmen Copper Project in Chile, signaling strong investor confidence and a clear path toward resource definition.

Delta Lithium has completed the demerger and IPO of its Mt Ida Gold asset into Ballard Mining, raising $30 million and retaining a 46% stake, while significantly expanding its lithium project tenure in Western Australia.

Unico Silver has confirmed a significant new silver-gold mineralised zone at La Morocha SE within its Joaquin Project, highlighting strong growth potential ahead of a revised resource estimate.

Prospect Resources has kicked off an extensive Phase 2 drilling campaign at its Mumbezhi Copper Project in Zambia, confirming promising copper grades and advancing metallurgical testing. A strategic $18.5 million investment from First Quantum Minerals strengthens its financial and technical position.

Tamboran Resources appoints Chairman Dick Stoneburner as interim CEO following Joel Riddle’s departure, while adding two seasoned energy executives to its board as it advances gas production plans in the Beetaloo Basin.

Botanix Pharmaceuticals reports a strong commercial ramp-up for Sofdra™, with net revenue jumping from $0.7 million to $4.3 million in one quarter, supported by a $40 million capital raise and a $30 million debt facility.

Skylark Minerals reports solid progress in its Simon Copper and Perseverance Projects with ongoing fieldwork analysis, while maintaining a strong cash position and advancing gold asset acquisitions.

Toubani Resources has made significant strides in developing its Kobada Gold Project in Mali, securing a $29 million strategic placement and launching extensive drilling programs aimed at expanding its mineral resource base ahead of a final investment decision.

Boss Energy has exceeded its FY25 production and cost targets at the Honeymoon Uranium Project, marking a major milestone of over 1 million pounds of uranium produced since commissioning. The company’s robust balance sheet and operational ramp-up position it well for growth amid a strengthening uranium market.

Artrya has launched its AI-powered Salix Coronary Anatomy platform in the U.S. and submitted its Coronary Plaque module for FDA clearance, marking a key step in its commercial expansion. A new five-year contract with Tanner Health signals the start of U.S. revenues.

Viridis Mining and Minerals has locked in a strategic US$30 million equity funding partnership with leading Brazilian asset managers to accelerate its Colossus Rare Earth Project towards production.

Elanor Investors Group announces a $125 million strategic investment from Rockworth Capital Partners to stabilise its balance sheet and fund growth, including the acquisition of Singapore’s Firmus Capital.